AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUL 2 - (NewsRx.com & NewsRx.net) -- Apoptotic cell death in conjunction with CD80 costimulation conferred uveal melanoma cells with the ability to induce immune responses.
"Uveal melanoma is a rare malignancy with a poor prognosis despite current therapeutic intervention. The current investigation focuses on the immunogenicity of uveal melanoma cells genetically modified with recombinant adenovirus encoding CD80 (AdCD80) in contrast to their parental counterpart. We demonstrate that costimulation provided by uveal melanoma cells improved immune responses in vitro as determined by mixed lymphocyte tumor cell cultures and cytotoxic T-cell assays using lymphocytes from healthy donors and uveal melanoma patients," researchers in England report.
"Flow cytometry revealed T-cell stimulation by activated CD4+ and CD8+ T cells," stated Jennifer Carlring and collaborators at the University of Sheffield. "Additionally, autologous lymphocytes proliferated in response to CD80-expressing primary uveal melanomas, indicating that this patient group is suitable for immunotherapy. Moreover, this study utilized AdCD80 modified and parental apoptotic tumor cells, loaded onto immature dendritic cells, as a source of tumor antigen. The ability of live or apoptotic tumor cells to stimulate lymphocyte ...
Source: HighBeam Research, Apoptosis plus CD80 costimulation promote immune response by melanoma...